DeltaGen Inc. (DGEN)
OTC
Closed
Aug 21, 2026
Day's Range
0.00010052 wk Range
0.000100Overview - DGEN - DeltaGen Inc.
Key Statistics
Valuation
Enterprise Value
2.03K
Price / Sales (TTM)
‪3.56‬
Price / Book
‪0.0018‬
Profitability
Profit Margin
‪-5.97%‬
Operating Margin
‪29.27%‬
Return on Assets
‪-1.58%‬
Return on Equity
‪-2.71%‬
Price stats
Beta
‪69.85‬
50-Day Avg
‪0.00010‬
200-Day Avg
‪0.00010‬
Dividends
Payout Ratio
‪504.60%‬
Frequency
Quarterly
Market Cap - DGEN - DeltaGen Inc.
Peers - DGEN - DeltaGen Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on OTC.
- DGENOTCDeltaGen Inc.2.74MMarket Cap+0.00%52-week change—P/E (Trailing)‪-5.97%‬Profit Margin
- ESLOYOTCEssilorLuxottica S.A. Unsponsored ADR87.51BMarket Cap-65.66%52-week change30.49P/E (Trailing)‪8.51%‬Profit Margin
- ESLOFOTCEssilorLuxottica86.26BMarket Cap-68.22%52-week change30.13P/E (Trailing)‪8.51%‬Profit Margin
- HOCPFOTCHOYA Corporation54.67BMarket Cap+17.83%52-week change34.70P/E (Trailing)‪27.17%‬Profit Margin
- HOCPYOTCHoya Corporation Sponsored ADR52.43BMarket Cap+17.18%52-week change33.34P/E (Trailing)‪27.17%‬Profit Margin
- RSMDFOTCResMed Inc. Chess Depositary Interest32.42BMarket Cap+26.02%52-week change21.62P/E (Trailing)‪26.94%‬Profit Margin
- SRTOYOTCSartorius Stedim Biotech S.A. Unsponsored ADR21.83BMarket Cap+7.97%52-week change64.67P/E (Trailing)‪9.73%‬Profit Margin
Profile Summary - DGEN - DeltaGen Inc.
About
DeltaGen Inc. is a leading biotech company specializing in genetic engineering and biotechnology solutions. The primary function of DeltaGen is to develop advanced genetic therapies and innovative biotechnological products that aim to address complex health challenges. With a focus on pioneering research in genomics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
